CRIS Current Research Information System

SCAIOLI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.039
EU - Europa 2.620
AS - Asia 2.252
SA - Sud America 142
AF - Africa 140
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.211
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.993
IT - Italia 1.052
SG - Singapore 634
VN - Vietnam 625
CN - Cina 476
GB - Regno Unito 446
SE - Svezia 247
DE - Germania 220
IN - India 142
HK - Hong Kong 140
FR - Francia 131
RU - Federazione Russa 106
BR - Brasile 102
IE - Irlanda 84
NL - Olanda 72
UA - Ucraina 71
ZA - Sudafrica 50
CH - Svizzera 35
JO - Giordania 35
CI - Costa d'Avorio 30
EE - Estonia 29
CA - Canada 27
JP - Giappone 26
PH - Filippine 25
TG - Togo 23
BG - Bulgaria 22
FI - Finlandia 22
BE - Belgio 21
TH - Thailandia 19
AR - Argentina 16
AU - Australia 16
KR - Corea 16
ES - Italia 15
ID - Indonesia 14
TR - Turchia 14
SA - Arabia Saudita 12
BD - Bangladesh 11
TW - Taiwan 11
MY - Malesia 10
AT - Austria 9
IR - Iran 9
PL - Polonia 9
SC - Seychelles 9
NG - Nigeria 8
EC - Ecuador 7
KE - Kenya 7
MX - Messico 7
CO - Colombia 6
IQ - Iraq 5
LB - Libano 5
LT - Lituania 5
RO - Romania 5
CL - Cile 4
HR - Croazia 4
HU - Ungheria 4
MU - Mauritius 4
BA - Bosnia-Erzegovina 3
BZ - Belize 3
HN - Honduras 3
IL - Israele 3
NP - Nepal 3
PE - Perù 3
PK - Pakistan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
ET - Etiopia 2
GR - Grecia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LY - Libia 2
MA - Marocco 2
NI - Nicaragua 2
PY - Paraguay 2
AL - Albania 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
GT - Guatemala 1
KZ - Kazakistan 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SL - Sierra Leone 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 8.211
Salva come PNG Salva come JPEG
Città #
Singapore 433
Southend 378
Ashburn 318
Fairfield 303
Chandler 244
Houston 227
Bologna 141
Hong Kong 129
Hanoi 128
Santa Clara 125
Woodbridge 125
Seattle 123
Ho Chi Minh City 116
Cambridge 112
San Jose 112
Ann Arbor 110
Wilmington 105
Beijing 90
Princeton 87
Dublin 78
Milan 59
Rome 57
Dong Ket 53
Boardman 52
Frankfurt am Main 50
Lauterbourg 44
Westminster 38
Los Angeles 37
Amman 34
Hefei 33
Abidjan 30
Padova 30
Nanjing 27
Berlin 25
Tokyo 25
Buffalo 24
Lomé 23
Bern 22
San Diego 21
Sofia 21
Capaccio 20
Council Bluffs 20
Dallas 20
Palermo 20
Saint Petersburg 20
Jinan 19
Pune 19
Turin 19
New York 18
Redondo Beach 18
Toronto 18
Da Nang 17
São Paulo 17
Changsha 16
Shenyang 15
Haiphong 14
Hebei 14
Helsinki 14
Johannesburg 14
Redwood City 14
Orem 13
Brussels 12
Jiaxing 12
Modena 12
Des Moines 11
Florence 11
Naples 11
The Dalles 11
Velletri 11
Bremen 10
Dearborn 10
Medford 10
Phoenix 10
Redmond 10
Sydney 10
Bari 9
Bengaluru 9
Chicago 9
Guangzhou 9
Nanchang 9
San Francisco 9
Seoul 9
Shanghai 9
Abeokuta 8
Atlanta 8
Kuala Lumpur 8
Munich 8
Warsaw 8
Bangkok 7
Castel Maggiore 7
Falkenstein 7
Genoa 7
Jacksonville 7
Kunming 7
Nairobi 7
Nha Trang 7
Norwalk 7
Potenza 7
Shenzhen 7
Verona 7
Totale 4.895
Salva come PNG Salva come JPEG
Nome #
Polifenoli ed efficacia antinfiammatoria: lo strano caso del melograno e le malattie croniche intestinali 933
Pomegranate: from the Promised Land to calm the fire in Inflammatory Bowel Disease 313
COVID-19 in IBD: The experience of a single tertiary IBD center 299
Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis 253
Clinical application of faecal calprotectin in ulcerative colitis patients 246
Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy 227
New Insight and Knowledge on anti-inflammatory Effectiveness of dietary phenolics: a work-in-progress report of the NIKE Project 223
Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial 223
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 215
Attachment and mentalizing abilities in patients with inflammatory bowel disease 203
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 197
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 197
Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch–Anal Anastomosis for Ulcerative Colitis 196
Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn’s disease, cause or epiphenomenon? 188
Can fecal calprotectin better stratify Crohn’s disease activity index? 188
Gut Microbiota and Celiac Disease 188
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 186
null 179
The Effect of Supplementing a Novel n-3 Polyunsaturated Fatty Acids Formulation Containing Schisandra chinensis Extract and Vitamin D3 to a Group of Elite Sport Athletes on Competition Related Stress, Anxiety and Self-confidence 177
Evidence for a Modulatory Effect of a 12‐Week Pomegranate Juice Intervention on the Transcriptional Response in Inflammatory Bowel Disease Patients Reducing Fecal Calprotectin Levels: Findings From a Proof‐of‐Principle Study 172
Influence of K-ras status and anti-tumour treatments on complications due to colorectal self-expandable metallic stents: A retrospective multicentre study 170
Nerve fiber overgrowth in patients with symptomatic diverticular disease 167
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 161
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 160
Aortic thrombosis recurrence in a Crohn's disease patient 160
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 156
Simkania negevensis in Crohn’s Disease 155
Calcolosi della colecisti complicata 149
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods. 149
Gut microbiota and its pathophysiology in disease paradigms. 149
Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection 144
Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply. 143
PROBABILISTIC ASSESSMENT OF SYMPTOMLESS INFLAMMATION IN CROHN’S DISEASE PATIENTS 143
Coeliac disease and autoimmune hepatitis: Gluten-free diet can influence liver disease outcome. 141
Bacteria flora,gas and antibiotics 139
Percutaneous liver biopsy in the clinical management of hepatocellular carcinoma:back to the future 132
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure 131
Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis 122
Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumor grading assessment 121
Calcolosi della colecisti 117
Calcolosi della via biliare principale 106
Natural history of small gallbladder polips is benign. Evidence from a clinical and pathogenetic study. 104
null 95
Extrahepatic cholangiocarcinoma: clinical features 86
MRI patterns in a case of 6-thioguanine-related hepatic sinusoidal obstruction syndrome 85
Totale 8.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.090
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021367 0 0 0 0 0 0 0 0 0 46 56 265
2021/20221.007 46 59 57 87 87 49 48 45 37 51 291 150
2022/20231.000 106 134 59 131 69 78 33 60 195 16 67 52
2023/2024449 25 51 51 39 45 83 31 23 27 33 15 26
2024/20251.202 69 164 81 85 217 58 103 51 42 79 55 198
2025/20262.236 175 156 177 195 254 173 267 112 555 172 0 0
Totale 8.388